Company intelligence / Profile preview
Polichem
Lugano, Ticino, Switzerlandpolichem.com ↗
- Ownership
- Private
- Employees
- ~85
- Development stage
- Commercial
01
Overview
Polichem has a long tradition in developing innovative pharmaceutical products with a strong focus on dermatology—especially nail diseases—and gynecology. The company has more than eight marketed products globally and holds over forty patents. It was acquired by Almirall S.A. in November 2015. Its lead areas are dermatological conditions such as onychomycosis and nail psoriasis; it also markets gynecological treatments like Nifuratel/Nystatin for vulvovaginal candidiasis.
- Therapeutic areas
- NeurologyPulmonologyDermatologyInfectious Diseases
- Modalities
- Small moleculesMedical devicesDermocosmetics
- Industry
- Biotech
02
Drug pipeline
14 assets13 more assets in the full pipeline.
Beyond the preview
Go deeper on Polichem.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Polichem.